LRRC8A and cardiac hypertrophy: We recently demonstrated that inhibiting LRRC8A expression in cardiomyocytes reduces angiotensin II-induced ventricular hypertrophy and dysfunction, giving the first evidence that LRRC8A functions as a key regulator of cardiovascular pathology 17.